Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Phase I Study of IMGN901 in Patients with Relapsed and Relapsed/Refractory CD56-Positive Multiple Myeloma

Asher Alban Chanan-Khan, MD, Mecide Gharibo, MD, Sundar Jagannath, MD, Nikhil C. Munshi, MD, Kenneth C Anderson, MD, Dawn DePaolo, Kelvin P. Lee, MD, Kena Miller, RN, MSN, FNP, Robin Guild, Sybil Zildjian, Albert Qin

Blood (2008) 112 (11): 3689.

https://doi.org/10.1182/blood.V112.11.3689.3689

Published: 2008

Journal Articles

Lenalidomide Associated Tumor Flare Reaction Correlates with Clinical Response in Patients with Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia

Taimur Sher, Mehul Patel, Amy Whitworth, Kena Miller, Laurie Musial, David Lawrence, Swaminathan Padmanabhan, Sikander Ailawadhi, Gregory Wilding, Dawn DePaolo, Naveen Bangia, Myron S. Czuczman, MD, Paul K. Wallace, MS, PhD, Kelvin P. Lee, MD, Asher Chanan Khan

Blood (2008) 112 (11): 4163.

https://doi.org/10.1182/blood.V112.11.4163.4163

Published: 2008

Journal Articles

Bortezomib in Combination with Pegylated Liposomal Doxorubicin and Thalidomide (VDT) for the Treatment of Previously Untreated Multiple Myeloma.

Asher A. Chanan-Khan, MD, Kena C. Miller, NP, Dawn DePaolo, Swaminathan Padmanabhan, MD, Amy Whitworth, Sikander Ailawadhi, MD, Kelvin Lee, MD, Myron S. Czuczman, MD

Blood (2007) 110 (11): 3614.

https://doi.org/10.1182/blood.V110.11.3614.3614

Published: 2007

Journal Articles

Phase I Study of huN901-DM1 (BB-10901) in Patients with Relapsed and Relapsed/Refractory CD56-Positive Multiple Myeloma.

Asher A. Chanan-Khan, MD, Sundar Jagannath, MD, Nikhil C. Munshi, MD, Robert L. Schlossman, MD, Kenneth C. Anderson, MD, Kelvin Lee, MD, Dawn DePaolo, Kena C. Miller, NP, Sybil Zildjian, Robert J. Fram, MD, Qin

Blood (2007) 110 (11): 1174.

https://doi.org/10.1182/blood.V110.11.1174.1174

Published: 2007

Journal Articles

Oral Acyclovir Is an Effective in Decreasing the Incidence of Bortezomib Associated Herpes Zoster in Patients with Multiple Myeloma.

Dawn DePaolo, Kena C. Miller, NP, Amy Whitworth, Alice Mohr, NP, Terry L. Mashtare, Jr., Gregory Wilding, Sikander Ailawadhi, MD, Swaminathan Padmanabhan, MD, Asher A. Chanan-Khan, MD

Blood (2007) 110 (11): 4844.

https://doi.org/10.1182/blood.V110.11.4844.4844

Published: 2007

Journal Articles

Phase I Study of BB-10901 (huN901-DM1) in Patients with Relapsed and Relapsed/Refractory CD56-Positive Multiple Myeloma.

Asher Alban Chanan-Khan, MD, Sundar Jagannath, MD, Robert L. Schlossman, MD, Robert J. Fram, MD, Richard M. Falzone, Mary F. Ruberti, Samantha K. Welch, Dawn DePaolo, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2006) 108 (11): 3574.

https://doi.org/10.1182/blood.V108.11.3574.3574

Published: 2006

Journal Articles

Weight Adjusted Low-Dose Warfarin Decreases the Incidence of Thalidomide (T) Associated Venous Thromboembolism (VTE) in Patients (pts) with Multiple Myeloma (MM) and Waldenstroms Macroglobulinemia (WM).

Kena C. Miller, NP, Rami Manochakian, Swaminathan Padmanabhan, MD, Jean-Gabriel Coignet, Laurie Musial, Dawn DePaolo, Asher Alban Chanan-Khan, MD

Blood (2006) 108 (11): 4101.

https://doi.org/10.1182/blood.V108.11.4101.4101

Published: 2006

Journal Articles

Incidence, Clinical Presentation and Outcome of Secondary Multiple Extramedullary Plasmacytomas: Experience at Roswell Park Cancer Institute.

Rami Manochakian, MD, Kena C. Miller, Jean-Gabriel Coignet, Swami Padmanabhan, MD, Laurie Musial, Dawn DePaolo, Asher Alban Chanan-Khan

Blood (2006) 108 (11): 5057.

https://doi.org/10.1182/blood.V108.11.5057.5057

Published: 2006

Journal Articles

Low-Dose Prednisone Decreases the Severity but Not the Frequency of Lenalidomide Associated Tumor Flare Feaction (TFR) in Chronic Lymphocytic Leukemia (CLL) Patients.

Laurie Musial, Kena C. Miller, Amy Tonelli, Rami Manochakian, Swaminathan Padmanabhan, David Lawrence, Dawn DePaolo, Jean-Gabriel Coignet, Asher Alban Chanan-Khan, MD

Blood (2006) 108 (11): 4987.

https://doi.org/10.1182/blood.V108.11.4987.4987

Published: 2006

Journal Articles

Characterization of IMiDs (Immunomodulating Agents) Induced “Flare Reaction” in Patients with Chronic Lymphocytic Leukemia (CLL) and Correlation with Changes in Serum Cytokine Levels.

Laurie DiMiceli, RN, Kena C. Miller, NP, Michael Rickert, Paul Wallace, MD, Patricia Marshall, Dawn DePaolo, Swaminathan Padmanabhan, MD, Beverly Landrigan, RN, Asher A. Chanan-Khan, MD

Blood (2005) 106 (11): 5049.

https://doi.org/10.1182/blood.V106.11.5049.5049

Published: 2005

NARROW

Phase I Study of IMGN901 in Patients with Relapsed and Relapsed/Refractory CD56-Positive Multiple Myeloma

Lenalidomide Associated Tumor Flare Reaction Correlates with Clinical Response in Patients with Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia

Bortezomib in Combination with Pegylated Liposomal Doxorubicin and Thalidomide (VDT) for the Treatment of Previously Untreated Multiple Myeloma.

Phase I Study of huN901-DM1 (BB-10901) in Patients with Relapsed and Relapsed/Refractory CD56-Positive Multiple Myeloma.

Oral Acyclovir Is an Effective in Decreasing the Incidence of Bortezomib Associated Herpes Zoster in Patients with Multiple Myeloma.

Phase I Study of BB-10901 (huN901-DM1) in Patients with Relapsed and Relapsed/Refractory CD56-Positive Multiple Myeloma.

Weight Adjusted Low-Dose Warfarin Decreases the Incidence of Thalidomide (T) Associated Venous Thromboembolism (VTE) in Patients (pts) with Multiple Myeloma (MM) and Waldenstroms Macroglobulinemia (WM).

Incidence, Clinical Presentation and Outcome of Secondary Multiple Extramedullary Plasmacytomas: Experience at Roswell Park Cancer Institute.

Low-Dose Prednisone Decreases the Severity but Not the Frequency of Lenalidomide Associated Tumor Flare Feaction (TFR) in Chronic Lymphocytic Leukemia (CLL) Patients.

Characterization of IMiDs (Immunomodulating Agents) Induced “Flare Reaction” in Patients with Chronic Lymphocytic Leukemia (CLL) and Correlation with Changes in Serum Cytokine Levels.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only